Neuroimmunologia
Responsable de grup
Publicacions (136)
Fernández-Velasco JI; Monreal E; Kuhle J; Meca-Lallana V; Meca-Lallana J; Izquierdo G; Oreja-Guevara C; Gascón-Giménez F; Sainz de la Maza S; Walo-Delgado PE; Lapuente-Suanzes P; Maceski A; Rodríguez-Martín E; Roldán E; Villarrubia N; Saiz A; Blanco Y; Diaz-Pérez C; Valero-López G; Diaz-Diaz J; Aladro Y; Brieva L; Íñiguez C; González-Suárez I; Rodríguez de Antonio LA; García-Domínguez JM; Sabin J; Llufriu S; Masjuan J; Costa-Frossard L; Villar LM
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology.
Frontiers in Immunology 13 842354-842354. .
de la Maza, SS; Maurino, J; Borges, M; Martín-Martínez, J; Sotoca, J; Alonso, A; Caminero, AB; Borrega, L; Sánchez-Menoyo, JL; Barrero-Hernández, FJ; Calles, C; Brieva, L; Blasco, MR; García-Soto, JD; del Campo-Amigo, M; Navarro-Cantó, L; Agüera, E; Garcés, M; Carmona, O; Gabaldón-Torres, L; Forero, L; Hervás, M; de Alda, LR; Gómez-Ballesteros, R; Castillo-Triviño, T
Measuring productivity loss in early relapsing-remitting multiple sclerosis
Multiple Sclerosis and Related Disorders 58 -. .
Ramo-Tello C; Blanco Y; Brieva L; Casanova B; Martínez-Cáceres E; Ontaneda D; Ramió-Torrentá L; Rovira À
Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses.
Journal of Personalized Medicine 12 -. .
Granell-Geli, J; Izquierdo-Gracia, C; Selles-Rius, A; Teniente-Serra, A; Presas-Rodriguez, S; Mansilla, MJ; Brieva, L; Sotoca, J; Mane-Martinez, MA; Moral, E; Bragado, I; Goelz, S; Martinez-Caceres, E; Ramo-Tello, C
Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab
Journal of Personalized Medicine 11 -. .
Munoz-Lopetegi, A; Pujol, M; Giménez, M; Gaig, C; Brieva, L; Santamaria, J
Abnormal sleep behavior caused by hypoglycemia
SLEEP MEDICINE 85 268-270. .
Jorge C; Cetó M; Arias A; Blasco E; Gil MP; López R; Dakterzada F; Purroy F; Piñol-Ripoll G
Level of understanding of Alzheimer disease among caregivers and the general population.
NEUROLOGIA 36 426-432. .
Meca-Lallana, J; García-Merino, JA; Martínez-Yélamos, S; Vidal-Jordana, A; Costa, L; Eichau, S; Rovira À; Brieva, L; Agüera, E; Zarranz, ARA
Identification of patients with relapsing multiple sclerosis eligible for high-efficacy therapies.
Neurodegenerative Disease Management 11 251-261. .
Sanchez-Cazalilla, Marta; Gonzalez-Mingot, Cristina; Torterolo, Giovanni; Torrent, Aurora; Batalla, Iolanda
Episodic Ataxia Misdiagnosed as Anxiety Disorder.
The Primary Care Companion For Cns Disorders 23 -. .
Maurino J; Sotoca J; Sempere ÁP; Brieva L; López de Silanes C; Caminero AB; Terzaghi M; Gracia-Gil J; Saposnik G
High-Efficacy Disease-Modifying Therapies in People with Relapsing-Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions.
Patient-Patient Centered Outcomes Research 14 241-248. .
Fernández-Velasco, JI; Kuhle, J; Monreal, E; Meca-Lallana, V; Meca-Lallana, J; Izquierdo, G; Gascón-Giménez, F; de la Maza, SS; Walo-Delgado, PE; Maceski, A; Rodríguez-Martín, E; Roldán, E; Villarrubia, N; Saiz, A; Blanco, Y; Sánchez, P; Carreón-Guarnizo, E; Aladro, Y; Brieva, L; Iniguez, C; González-Suárez, I; de Antonio, LAR; Masjuan, J; Costa-Frossard, L; Villar, LM
Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS
Neurology-Neuroimmunology & Neuroinflammation 8 940-. .
Purroy F; Vicente-Pascual M; Arque G; Baraldes-Rovira M; Begue R; Gallego Y; Gil MI; Gil-Villar MP; Mauri G; Quilez A; Sanahuja J; Vazquez-Justes D
Sex-Related Differences in Clinical Features, Neuroimaging, and Long-Term Prognosis After Transient Ischemic Attack.
STROKE 52 424-433. .
Casado V.; Bonaventura I.; Brieva L.; Martínez-Yélamos S.; Martín G.; Presas-Rodriguez S.; Hervas M.; Hernández J.J.; Munteis E.; Escartin A.; Gubieras L.; Mañé-Martínez M.A.; Ramió-Torrentà L.
Costes directos de los brotes en pacientes con esclerosis múltiple remitente-recurrente
Neurology Perspectives 1 160-169. .